Skip to main content
Caplight Logo









4G Clinical

4G Clinical

Private
Wellesley, MassachusettsHealthcare & Life Scienceshttps://www.4gclinical.com/

Last Round

Growth Equity

Jun 29, 2021

Total Funding Raised

$252.1M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

4G Clinical is a healthtech company that provides a cloud-based randomization and trial supply management (RTSM) platform for the life sciences industry.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Pharma Supply Chain, Vertical SaaS, Supply Chain

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

randomization and trial supply managementRTSMclinical trial softwareclinical supply chaineClinicalsupply chain forecastingpredictive analyticsclinical trial logisticspatient enrollment forecastingSaaS clinical platformclinical trial technologydrug supply managementclinical trial automationclinical operationslife sciences software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

4G Clinical Comparables

Compare 4G Clinical with similar companies based on industry and business-model similarity.

4G Clinical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Suvoda
91%
Dassault Systèmes
84%
Oracle Solaris
83%

4G Clinical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityJun 29, 2021
Series BJan 29, 2020
Series A ExtensionOct 19, 2016
Series AJan 29, 2016

Key People

Founding team and executive leadership

Rob Campanella

Chief Technology Officer

Executive Team

Anne Hinkle

Chief Financial Officer

Executive Team

4G Clinical Investors

Notable investors and investment history

4G Clinical investors
InvestorRounds
First AnalysisSeries B
Goldman Sachs Asset Management Private EquityGrowth Equity
Schooner CapitalSeries B, Series A, Series A Extension
Goldman Sachs Growth EquityGrowth Equity
Goldman Sachs & Co. LLCGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 190, 47% of headcount.

  • Jul 13, 2026

    Open roles increased to 94, 8.2x the trailing average.

4G Clinical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

4G Clinical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 4G Clinical's valuation, stock price, and market status.

Firmographic Details

HeadquartersWellesley, Massachusetts
Employee Range408
Year Founded2015
Last FundingJun 29, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?